People with type 1 diabetes who need to lose weight can benefit from the blockbuster GLP-1 drug semaglutide currently approved only for type 2 diabetes, according to results from a small trial.

CHMP recommends a label update for Novo Nordisk's Ozempic after the STRIDE study shows walking improvements in T2D patients with PAD.

In addition, Novo Nordisk said it has filed for a label expansion for Rybelsus with the EMA and FDA. This could potentially make Rybelsus the first and only oral GLP-1 RA with proven ...

Q: My doctor is suggesting that I try taking one of those new weight loss drugs -- off-label -- to help me cut down on my alcohol consumption. Does this make any sense? -- Pat R., Ann Arbor, Michigan ...

Compared to its predecessor, though, the AMD Radeon RX 9060 XT basically takes the same specs of the RX 7600 XT and moves them to a new graphics architecture, along with some faster memory.

The RX 9060 XT has a version with 16 GB of VRAM while the RTX 5060 only has 8 GB. The RX 9060 XT will future-proof your gaming PC for many years to come.

A simple oversight could end up costing Danish pharma giant Novo Nordisk A/S (NYSE: NVO) billions in potential losses on its blockbuster weight-loss and diabetes drug, Ozempic.